Advancements in the radiooncological Treatment of High-risk Prostate Cancer: A Quarter Century of Achievements

BACKGROUND: The aim of the study was to evaluate the development of treatment of primary high-risk prostate cancer in regards to biochemical no evidence of disease (bNED), acute and late gastrointestinal (GI) and genitourinary (GU) side effects. PATIENTS AND METHODS: Primary high-risk prostate cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Matthias, Herrmann, Harald, Zaharie, Alexandru, Goldner, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400444/
https://www.ncbi.nlm.nih.gov/pubmed/35502906
http://dx.doi.org/10.2478/raon-2022-0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400444/
https://www.ncbi.nlm.nih.gov/pubmed/35502906
http://dx.doi.org/10.2478/raon-2022-0018

Ejemplares similares